1. Home
  2. AMBA vs SYRE Comparison

AMBA vs SYRE Comparison

Compare AMBA & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$71.37

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$32.94

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
SYRE
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
AMBA
SYRE
Price
$71.37
$32.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
6
Target Price
$97.25
$56.50
AVG Volume (30 Days)
844.3K
899.1K
Earning Date
11-25-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$373,850,000.00
N/A
Revenue This Year
$39.65
N/A
Revenue Next Year
$9.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.08
N/A
52 Week Low
$38.86
$10.91
52 Week High
$96.69
$35.31

Technical Indicators

Market Signals
Indicator
AMBA
SYRE
Relative Strength Index (RSI) 40.69 61.17
Support Level $69.62 $32.50
Resistance Level $74.58 $34.84
Average True Range (ATR) 2.78 1.45
MACD 0.08 -0.41
Stochastic Oscillator 18.68 23.11

Price Performance

Historical Comparison
AMBA
SYRE

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: